ALLO 10-Q: SEC filing
Allogene Therapeutics
Filed with the SEC on · accession 0001628280-26-071191
ALLO filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. Allogene Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing continued use of its at-the-market (ATM) equity offering program and a prior public offering.
Summary of the filing
Allogene Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing continued use of its at-the-market (ATM) equity offering program and a prior public offering. The filing reflects ongoing clinical-stage operations with no single material corporate event.
Key details
✦ Ask GOAX AI about this filing — what it means for ALLO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ALLO?
Click hereFrequently asked questions
What did ALLO file with the SEC on Nov 6, 2026?
ALLO filed a 10-Q (SEC filing). Allogene Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing continued use of its at-the-market (ATM) equity offering program and a prior public offering. The filing reflects ongoing clinical-stage operations with no single material corporate event.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other ALLO SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · Cfo changeSep 2, 2026
- EFFECT · SEC filingAug 20, 2026
- 10-Q · SEC filingAug 12, 2026
- S-3 · Shelf registrationAug 12, 2026
- 8-K · SEC filingAug 12, 2026
- 8-K · Secondary offeringJun 22, 2026
- 424B5 · Secondary offeringJun 22, 2026
- 8-K · Ceo changeMay 28, 2026
- 10-Q · SEC filingMay 13, 2026
Get alerts when ALLO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days